Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:19 AM EDT

Biomea Fusion (BMEA) Other Accumulated Expenses (2021 - 2026)

Biomea Fusion's (BMEA) quarterly Other Accumulated Expenses came in at $191000.0 in Q2 2026, down 9.05% year-over-year from $210000.0 in Q2 2025, and up 20.13% quarter-over-quarter from $159000.0 in Q1 2026.

Analysis

Biomea Fusion (BMEA) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

Biomea Fusion has disclosed Other Accumulated Expenses across 6 years of filings, most recently posting $191000.0 for Q2 2026.

  • In Q2 2026, Other Accumulated Expenses fell 9.05% year-over-year to $191000.0; the TTM figure through Jun 2026 stood at $191000.0 (down 9.05% YoY), while the FY2025 annual figure was $169000.0, down 16.75% from the prior year.
  • Other Accumulated Expenses came in at $191000.0 for Q2 2026 at Biomea Fusion, up from $159000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $636000.0 in Q4 2022 to a low of $144000.0 in Q3 2025.
  • Average Other Accumulated Expenses over 5 years is $282833.3, with a median of $212500.0 recorded in 2024.
  • Year-over-year, Other Accumulated Expenses surged 111.88% in 2022 and slumped 69.81% in 2023.
  • Over 5 years, Other Accumulated Expenses stood at $636000.0 in 2022, then sank by 69.81% to $192000.0 in 2023, then advanced by 5.73% to $203000.0 in 2024, then retreated by 16.75% to $169000.0 in 2025, then advanced by 13.02% to $191000.0 in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $191000.0 in Q2 2026, $159000.0 in Q1 2026, and $169000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Biomea Fusion 132.65 Mn 132.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191,000.00
Mar 31, 2026 159,000.00
Dec 31, 2025 169,000.00
Sep 30, 2025 144,000.00
Jun 30, 2025 210,000.00
Mar 31, 2025 261,000.00
Dec 31, 2024 203,000.00
Sep 30, 2024 146,000.00
Jun 30, 2024 215,000.00
Mar 31, 2024 226,000.00
Dec 31, 2023 192,000.00
Sep 30, 2023 164,000.00
Jun 30, 2023 399,000.00
Mar 31, 2023 425,000.00
Dec 31, 2022 636,000.00
Sep 30, 2022 428,000.00
Jun 30, 2022 449,000.00
Mar 31, 2022 474,000.00
Dec 31, 2021 480,000.00
Sep 30, 2021 202,000.00
API Access

Biomea Fusion Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BMEA&period=max&api_key=YOUR_API_KEY